Navigation Links
Indication of considerable added benefit of vemurafenib in advanced melanoma
Date:1/8/2013

erences between the treatment groups - and hence also no indication of an added benefit of vemurafenib. As regards the quality of life (including physical and emotional well-being), there were no differences, so here, too, an added benefit is not proven.

Major potential harm in the form of side effects

Overall, the side effect profile of vemurafenib is less favourable than that of dacarbazine, because severe adverse events (according to the Common Terminology Criteria for Adverse Events (CTCAE) Grade ≥ 3) and serious adverse events were more frequent in patients who received vemurafenib. The proportion of those who discontinued the treatment due to side effects was comparable in the treatment groups. All in all, IQWiG sees an indication of greater harm from vemurafenib and rates its extent as "major".

Potential for harm reduces the extent of the added benefit

In order to derive proof of benefit from a single study, it must meet special requirements. This particular study does not fulfil them. Therefore no conclusions with the highest probability (proof) are possible - for example, on added benefit; at most indications can be derived from the study.

In summary, there are positive and negative results of the same degree of certainty (indications). On the positive side, the greatest extent - namely "major" - is attained for overall survival. On the negative side, due to side effects, there is an indication of greater harm, and this is also of major extent. For this reason, the Institute downgrades the overall added benefit of vemurafenib relative to the appropriate comparator therapy with dacarbazine from "major" to "considerable".

G-BA decides on the extent of added benefit

The dossier assessment is part of the overall procedure for early benefit assessment conducted by the G-BA. After publication of the manufacturer's dossier and its assessment by IQWiG, the G-BA initiates a
'/>"/>

Contact: Dr. Anna-Sabine Ernst
presse@iqwig.de
0049-221-356-850
Institute for Quality and Efficiency in Health Care
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Antibody-coated stents: Indication of disadvantages
2. Abiraterone: Indication of considerable added benefit in certain patients
3. Considerable added benefit of ipilimumab in advanced melanoma
4. Marketing Xocolate International Corporation (MXI-Corp) Introduces Xe Healthy Energy Drink, A Rich And Delicious Antioxidant Beverage, Now Added to Xoçai™ Product Line
5. Capsiplex Plus Reviews for Improved Weight Loss Supplement Added to BestAppetiteSuppressantPills.com
6. UV-Aid Cold and Flu Prevention Added to List of Biomimicry Strategies on AskNature.Org
7. Healthy Chocolate Omega Squares, a Decedent Dark Chocolate Added to Marketing Xocolate International Corporation (MXI Corp) Product Lines
8. Rilpivirine for HIV: Added benefit for single agent proven
9. US Drug Watchdog Has Added Wright, Stryker, Biomet, and Zimmer To Their Initiative For All Metal Hip Implant Failures Victims & Offers Them The Names Of The Best Lawyers
10. CFO 911 Solutions' Charles K. Dargan II, CEO, and Reid Dabney, Managing Director Have Been Added to the Financial Entrepreneur Platform ("FEP") of Merriman Capital, Inc., a Wholly Owned Subsidiary of Merriman Holdings, Inc. (OTCQX: MERR)
11. Vandetanib in thyroid cancer: No proof of added benefit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... ... 05, 2015 , ... Paradise Valley Community College (PVCC) is proud ... of their work at Paradise Valley Community College. , PVCC Fine and Performing Arts ... The artists will be on hand to meet the public and discuss their work, ...
(Date:9/4/2015)... ... 2015 , ... With TransCel from Pixel Film Studios users can simulate celluloid ... With TransCel users have full control over camera position and angle within 3D space ... inner color, text, and more. With TransCel the possibilities are endless. , Users have ...
(Date:9/4/2015)... ... September 04, 2015 , ... Georgia Insurance Advisors, ... a charity effort to provide for the family of Grace, a young local ... restrictive cardiomyopathy often leads to diastolic dysfunction – the inability to adequately move ...
(Date:9/4/2015)... ... , ... Keeping mold top of mind is important when considering indoor air ... grow anywhere - on carpet, clothing, food, paper, and even in places you can’t ... the home is key to preventing mold growth, which if exposed to can lead ...
(Date:9/4/2015)... ... September 04, 2015 , ... Bio-Logic Aqua® Research, a fresh ... its only mission and research focus: Water Life Science®. In the current warming ... evaporation is becoming dangerously accelerated. As a result of the global fresh water, ...
Breaking Medicine News(10 mins):Health News:Paradise Valley Community College Announces Master Ceramic Artists & Exhibit 2Health News:Pixel Film Studios Releases TransCel, a New FCPX Transition 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 3Health News:September is Mold Awareness Month 2Health News:September is Mold Awareness Month 3Health News:September is Mold Awareness Month 4Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 2Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 3
... TUESDAY, Jan. 31 (HealthDay News) -- Experts comparing three leading ... more toxic and expensive than either surgery or a more ... findings were to be presented Tuesday at a meeting in ... Clinical Oncology (ASCO) and focused on prostate cancer. "Research ...
... HealthDay Reporter , TUESDAY, Jan. 31 (HealthDay News) -- ... boost survival for men with advanced prostate cancer, studies suggest. ... stopped early to make sure all participants could benefit from ... known as "metastatic castration-resistant prostate cancers" -- tumors that ...
... Philadelphia, PA, January 31, 2011 Back problems are ... condition have a significantly greater chance of retiring early ... other health condition. A group of Australian researchers ... immediate income available to these individuals, but it also ...
... hygiene could cut the spread of flu-like symptoms up to ... A new report shows the second-year results (2007-2008) of the ... reduction in flu-like illness over the study period when using ... Allison Aiello, associate professor of epidemiology in the U-M School ...
... researchers have developed a better way to detect the slight ... type of cancer or other diseases. Their results are ... Angewandte Chemie . This work could advance understanding ... in personalized medicine, which aims to target drugs and other ...
... (HealthDay News) -- Using stem cells to create liver-like ... out why people respond differently to hepatitis C infection, ... are resistant to hepatitis C, while others are highly ... inflammation and organ failure. Studying liver cells from ...
Cached Medicine News:Health News:Study Compares 3 Common Prostate Cancer Treatments 2Health News:Study Compares 3 Common Prostate Cancer Treatments 3Health News:Study Compares 3 Common Prostate Cancer Treatments 4Health News:Experimental Drugs Do Battle Against Advanced Prostate Cancer 2Health News:Experimental Drugs Do Battle Against Advanced Prostate Cancer 3Health News:People who retire early due to back problems face long-term financial disadvantage 2Health News:Pairing masks and hand washing could drastically slow spread of pandemic flu 2Health News:Genes linked to cancer could be easier to detect with liquid lasers 2
(Date:9/4/2015)... Future Prospects for Companies in Antihistamines, Corticosteroids, ... - new study showing you trends, partnerships, and ... allergic rhinitis drugs heading? What are the commercial prospects ... you potential revenues and other trends to 2025, discussing ... report provides 273 tables, charts, and graphs. Discover the ...
(Date:9/4/2015)... , Sep. 04, 2015 ... of the "Investigation Report on China,s Sodium Ibandronate Market, ... and used in the clinic under the trade name of ... Austria in 1996, sodium ibandronate was approved by ... treatment of osteoporosis under the trade name of Boniva. However, ...
(Date:9/4/2015)... September 4, 2015 Hutchison ... that Hutchison MediPharma Limited ("HMP"), its drug R&D ... second proof-of-concept ("POC") trial of fruquintinib in patients ... in China .  The top-line ... meeting the primary efficacy endpoint of progression free ...
Breaking Medicine Technology:Allergic Rhinitis Drugs Market Forecast 2015-2025 2Allergic Rhinitis Drugs Market Forecast 2015-2025 3Allergic Rhinitis Drugs Market Forecast 2015-2025 4Allergic Rhinitis Drugs Market Forecast 2015-2025 5Allergic Rhinitis Drugs Market Forecast 2015-2025 6Allergic Rhinitis Drugs Market Forecast 2015-2025 7Investigation Report on China's Sodium Ibandronate Market 2010-2019 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 3
... Late Stage Clinical Therapeutic Cancer... -- TUEBINGEN, Germany, September 21, 2010 ... ... ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. ...
... Inc., today announced that it reported positive preclinical ... Association for the Study of Diabetes (EASD).  CCX140, ... the chemokine receptor CCR2, improved metabolic function while ... in an animal model, and was well tolerated ...
Cached Medicine Technology:immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 2immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 3immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 4immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 5immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 6immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 7immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 8immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 9immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 10ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD) 2ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD) 3ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD) 4
... 3085 SP Surgical Table provides state-of-the-art voice-activated ... be networked with the HERMES Control Center ... Endoscopy) to allow the surgeon direct control ... uses either simple voice commands or a ...
... 3085 SP Surgical Table combines innovation and ... weighing up to 1,000 lbs. You can ... both normal and reverse orientation and have ... other patients.,The Amsco 3085 SP Table offers ...
The Acumed Great Toe System is a two-piece non-constrained implant for the first MP joint. The system was developed to provide ease of use for the surgeon, combined with precise instrumentation and a...
... SCREW SYSTEM for the Orthopedic Foot and ... can be used for small bone osteotomies, ... two simplified screw sizes in one compact ... unique set of instrumentation. These lag ...
Medicine Products: